Publications
2022
Original Articles
Barker, R. A., Boer, G. J., Cattaneo, E., Charo, R. A., Lopes, S., Cong, Y. L., Fujita, M., Goldman, S., Hermeren, G., Hyun, I., Lisgo, S., Rosser, A. E., Anthony, E., & Lindvall, O. (2022). The need for a standard for informed consent for collection of human fetal material. Stem Cell Reports, 17(6), 1245-1247. doi:10.1016/j.stemcr.2022.05.013
Fujita, M., Hatta, T., & Ide, K. (2022). Current status of cell-based interventions in Japan. Cell Stem Cell, 29(9), 1294-1297. doi:10.1016/j.stem.2022.08.003
Hatta, T., Ide, K., Fujita, M., & Ikka, T. (2022). Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan. Stem Cell Reports, 17(5), 1016-1018. doi:10.1016/j.stemcr.2022.03.015
Murata, M., Kawabe, K., Hatta, T., Maeda, S., & Fujita, M. (2022). Current status of umbilical cord blood storage and provision to private biobanks by institutions handling childbirth in Japan. Bmc Medical Ethics, 23(1). doi:10.1186/s12910-022-00830-8
Sato, H., Fujita, M., Tsuchiya, A., Hatta, T., Mori, K., Nakazawa, E., Takimoto, Y., & Akabayashi, A. (2022). Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study. Biopsychosocial Medicine, 16(1). doi:10.1186/s13030-022-00247-0
2021
Original Papers
Ide, K., Koshiba, H., Hawke, P., & Fujita, M. (2021). Guidelines Are Urgently Needed for the Use of Preprints as a Source of Information. Journal of Epidemiology, 31(1). 97-99. https://doi.org/10.2188/jea.JE20200506
Sawai, T., Hayashi, Y., Niikawa, T., Shepherd, J., Thomas, E., Lee, T. L., Erler, A., Watanabe, M., & Sakaguchi, H. (2021). Mapping the Ethical Issues of Brain Organoid Research and Application. AJOB Neurosci, 1-14. https://doi.org/10.1080/21507740.2021.1896603
2020
Original Papers
Sawai, T., Minakawa, T., Pugh, J., Akatsuka, K.,Yamashita, J. K., & Fujita, M. (2020). The moral status of humanembryo-like structures: potentiality matters? The moral status of humansynthetic embryos. Embo Reports, 21(8). https://doi.org/10.15252/embr.202050984
Crane, A. T., Shen, F. X., Brown, J. L., Cormack, W.,Ruiz-Estevez, M., Voth, J. P., Sawai, T., Hatta, T., Fujita, M., &Low, W. C. (2020). The American Public Is Ready to Accept Human-Animal ChimeraResearch. Stem Cell Reports, 15(4), 804-810. https://doi.org/10.1016/j.stemcr.2020.08.018
Akatsuka, K., Sasaki-Honda, M., & Sawai, T.(2020). Ethical Framework for Next-Generation Genome and Epigenome Editing. AmJ Bioeth, 20(8), 32-36. https://doi.org/10.1080/15265161.2020.1782524
2019
Original Papers
Sawai, T., Hatta, T., & Fujita, M. (2019). Japan Significantly Relaxes Its Human-Animal Chimeric Embryo Research Regulations. Cell Stem Cell, 24(4), 513-514. https://doi.org/10.1016/j.stem.2019.03.015
Sawai, T., Sakaguchi, H., Thomas, E., Takahashi, J., & Fujita, M. (2019). The Ethics of Cerebral Organoid Research: Being Conscious of Consciousness. StemCell Reports, 13(3), 440-447. https://doi.org/10.1016/j.stemcr.2019.08.003
Ozeki-Hayashi, R., Fujita, M., Tsuchiya, A., Hatta, T., Nakazawa, E., Takimoto, Y., &Akabayashi, A. (2019). Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: a qualitative study. Breast Cancer-Targets and Therapy, 11, 221-229. https://doi.org/10.2147/bctt.s208910
Other Article
Fujita, M., & Tabuchi, K. (2019). A rebuttal to Akabayashi and colleagues’ criticisms of the iPSC stock project. J Med Ethics, 45(7), 476-477. https://https://doi.org/10.1136/medethics-2018-105248